For decades, drug developers have relied on animal models that poorly predict human outcomes. Revalia changes this by enabling researchers to test compounds directly on donated, perfused human organs — generating human data years before clinical trials begin.
Define research objectives and desired outcomes
Structure the study with rigor and precision
Match suitable donors to trial requirements
Conduct research with expert surgical support
Collect multi-modal biological data layers
Analyze and interpret results with Rio Insight
Apply findings to advance your pipeline
* Human Data Trials leverage donated human organs in a rigorous, IRB-compliant framework with academic and transplant partners.
Ready to accelerate your next program? Schedule a meeting with our team to explore how Human Data Trials can transform your pipeline.